P155 The impact of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on occurrence of bacterial lung infections in cystic fibrosis patients

Saved in:
Bibliographic Details
Published in:Journal of cystic fibrosis 2023-06, Vol.22, p.S112-S112
Main Authors: Cariani, L., Alicandro, G., Teri, A., Girelli, D., Orena, B.S.O., Liporace, M.F., Zatelli, M., Ceriotti, F., Blasi, F.B.A., Dacco, V.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1569-1993
1873-5010
DOI:10.1016/S1569-1993(23)00530-1